358 related articles for article (PubMed ID: 15549394)
1. The impact of MECP2 mutations in the expression patterns of Rett syndrome patients.
Ballestar E; Ropero S; Alaminos M; Armstrong J; Setien F; Agrelo R; Fraga MF; Herranz M; Avila S; Pineda M; Monros E; Esteller M
Hum Genet; 2005 Jan; 116(1-2):91-104. PubMed ID: 15549394
[TBL] [Abstract][Full Text] [Related]
2. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.
Amir RE; Van den Veyver IB; Wan M; Tran CQ; Francke U; Zoghbi HY
Nat Genet; 1999 Oct; 23(2):185-8. PubMed ID: 10508514
[TBL] [Abstract][Full Text] [Related]
3. Rett syndrome: the complex nature of a monogenic disease.
Renieri A; Meloni I; Longo I; Ariani F; Mari F; Pescucci C; Cambi F
J Mol Med (Berl); 2003 Jun; 81(6):346-54. PubMed ID: 12750821
[TBL] [Abstract][Full Text] [Related]
4. The biological functions of the methyl-CpG-binding protein MeCP2 and its implication in Rett syndrome.
Nan X; Bird A
Brain Dev; 2001 Dec; 23 Suppl 1():S32-7. PubMed ID: 11738839
[TBL] [Abstract][Full Text] [Related]
5. Histone modifications in Rett syndrome lymphocytes: a preliminary evaluation.
Kaufmann WE; Jarrar MH; Wang JS; Lee YJ; Reddy S; Bibat G; Naidu S
Brain Dev; 2005 Aug; 27(5):331-9. PubMed ID: 16023547
[TBL] [Abstract][Full Text] [Related]
6. X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain.
Braunschweig D; Simcox T; Samaco RC; LaSalle JM
Hum Mol Genet; 2004 Jun; 13(12):1275-86. PubMed ID: 15115765
[TBL] [Abstract][Full Text] [Related]
7. Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations.
Amir RE; Zoghbi HY
Am J Med Genet; 2000; 97(2):147-52. PubMed ID: 11180222
[TBL] [Abstract][Full Text] [Related]
8. MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain.
Balmer D; Arredondo J; Samaco RC; LaSalle JM
Hum Genet; 2002 Jun; 110(6):545-52. PubMed ID: 12107440
[TBL] [Abstract][Full Text] [Related]
9. A case of Rett syndrome from Ukraine--clinical diagnosis confirmed by mutation analysis of the MECP2 gene.
Bzduch V; Zahorakova D; Grechanina E; Zdibskaja EP; Goldfarb IG; Zeman J; Martasek P
Bratisl Lek Listy; 2004; 105(9):299-302. PubMed ID: 15633890
[TBL] [Abstract][Full Text] [Related]
10. Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry.
LaSalle JM; Goldstine J; Balmer D; Greco CM
Hum Mol Genet; 2001 Aug; 10(17):1729-40. PubMed ID: 11532982
[TBL] [Abstract][Full Text] [Related]
11. A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome.
Buschdorf JP; Strätling WH
J Mol Med (Berl); 2004 Feb; 82(2):135-43. PubMed ID: 14618241
[TBL] [Abstract][Full Text] [Related]
12. MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome.
Wan M; Zhao K; Lee SS; Francke U
Hum Mol Genet; 2001 May; 10(10):1085-92. PubMed ID: 11331619
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of the HDAC 1, 2, 8 and CDKL5 genes in Rett syndrome patients without mutations in MECP2.
Huppke P; Ohlenbusch A; Brendel C; Laccone F; Gärtner J
Am J Med Genet A; 2005 Aug; 137(2):136-8. PubMed ID: 16086395
[TBL] [Abstract][Full Text] [Related]
14. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome.
Horike S; Cai S; Miyano M; Cheng JF; Kohwi-Shigematsu T
Nat Genet; 2005 Jan; 37(1):31-40. PubMed ID: 15608638
[TBL] [Abstract][Full Text] [Related]
15. Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: pathological mutations and polymorphisms.
Fukuda T; Yamashita Y; Nagamitsu S; Miyamoto K; Jin JJ; Ohmori I; Ohtsuka Y; Kuwajima K; Endo S; Iwai T; Yamagata H; Tabara Y; Miki T; Matsuishi T; Kondo I
Brain Dev; 2005 Apr; 27(3):211-7. PubMed ID: 15737703
[TBL] [Abstract][Full Text] [Related]
16. Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders.
Samaco RC; Nagarajan RP; Braunschweig D; LaSalle JM
Hum Mol Genet; 2004 Mar; 13(6):629-39. PubMed ID: 14734626
[TBL] [Abstract][Full Text] [Related]
17. MeCP2 and other methyl-CpG binding proteins.
Jørgensen HF; Bird A
Ment Retard Dev Disabil Res Rev; 2002; 8(2):87-93. PubMed ID: 12112733
[TBL] [Abstract][Full Text] [Related]
18. Altered methylation pattern of the G6 PD promoter in Rett syndrome.
Huppke P; Bohlander S; Krämer N; Laccone F; Hanefeld F
Neuropediatrics; 2002 Apr; 33(2):105-8. PubMed ID: 12075494
[TBL] [Abstract][Full Text] [Related]
19. Association by guilt: identification of DLX5 as a target for MeCP2 provides a molecular link between genomic imprinting and Rett syndrome.
Bapat S; Galande S
Bioessays; 2005 Jul; 27(7):676-80. PubMed ID: 15954098
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the MECP2 gene in Japanese patients with Rett syndrome.
Amano K; Nomura Y; Segawa M; Yamakawa K
J Hum Genet; 2000; 45(4):231-6. PubMed ID: 10944854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
